<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00843297</url>
  </required_header>
  <id_info>
    <org_study_id>COOL-Trial</org_study_id>
    <nct_id>NCT00843297</nct_id>
  </id_info>
  <brief_title>COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest</brief_title>
  <acronym>COOL</acronym>
  <official_title>Clinical and Neurological Outcome With Two Different Cooling Methods (Invasive and Non-invasive) After Sudden Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sudden cardiac arrest (SCA) remains one of the major leading causes of death. Cognitive
      deficits are common in survivors of SCA. Postresuscitative mild induced hypothermia (MIH)
      lowers mortality and reduces neurologic damage after cardiac arrest. The investigators
      evaluated the efficacy and side effects of therapeutic hypothermia in an unselected group of
      patients after SCA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive patients with restoration of spontaneous circulation (ROSC) after resuscitation
      due to out-of-hospital SCA, admitted to our intensive care unit, underwent MIH. Hypothermia
      was induced by infusion of cold saline and whole-body-cooling methods (electronic
      randomization: invasive Coolgard or non-invasive ArcticSun). The core body temperature was
      operated at 32 to 34 °C over a period of 24 hours followed by active rewarming. Neurological
      status was evaluated at hospital discharge and 6 months after discharge using the Pittsburgh
      Cerebral Performance Category (CPC). Blood samples of neuron-specific enolase (NSE) were
      collected during 72 hours.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to reach the target temperature</measure>
    <time_frame>Twenty-four hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>NSE as a parameter for cerebral damage</measure>
    <time_frame>Seventy-two hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurologic outcome</measure>
    <time_frame>Six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>Six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Periprocedural complications</measure>
    <time_frame>Seventy-two hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cardiac Arrest</condition>
  <condition>Hypothermia</condition>
  <arm_group>
    <arm_group_label>CG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coolgard: invasive Cooling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ArcticSun: Surface-Cooling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UnCOOL</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>No Cooling-Therapy due to non-operational cooling-devices</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coolgard</intervention_name>
    <description>invasive Cooling via femoral ICY-catheter</description>
    <arm_group_label>CG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ArcticSun</intervention_name>
    <description>Noninvasive surface-cooling by saline-cooled thermo-vest</description>
    <arm_group_label>AS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional treatment</intervention_name>
    <description>Intensive care-treatment without cooling</description>
    <arm_group_label>UnCOOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ROSC after SCA due to VF/VT or PEA/Asystolia

          -  GCS 3

        Exclusion Criteria:

          -  Non-cardiac SCA

          -  Pregnancy

          -  Unstable Circulation instead of High-dose Inotropics

          -  Life-expectancy reducing concomitant illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holger Thiele, Associate Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study Chair</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Undine Pittl, MD</last_name>
    <role>Study Director</role>
    <affiliation>Study Sub-Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Leipzig, Heart Center, Cardiology</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Zeiner A, Holzer M, Sterz F, Behringer W, Schörkhuber W, Müllner M, Frass M, Siostrzonek P, Ratheiser K, Kaff A, Laggner AN. Mild resuscitative hypothermia to improve neurological outcome after cardiac arrest. A clinical feasibility trial. Hypothermia After Cardiac Arrest (HACA) Study Group. Stroke. 2000 Jan;31(1):86-94.</citation>
    <PMID>10625721</PMID>
  </reference>
  <reference>
    <citation>Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002 Feb 21;346(8):557-63.</citation>
    <PMID>11856794</PMID>
  </reference>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2009</study_first_submitted>
  <study_first_submitted_qc>February 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2009</study_first_posted>
  <last_update_submitted>February 1, 2010</last_update_submitted>
  <last_update_submitted_qc>February 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Holger Thiele, Assistant Professor</name_title>
    <organization>University of Leipzig, Heart Center</organization>
  </responsible_party>
  <keyword>Sudden Cardiac Arrest</keyword>
  <keyword>Hypothermia</keyword>
  <keyword>Outcome, neurological</keyword>
  <keyword>Coolgard</keyword>
  <keyword>ArcticSun</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

